ABACAVIR SULFATE
Substance profile for UNII J220T4J9Q2, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 441384Substance Identity#
- UNII
- J220T4J9Q2
- Preferred term
- ABACAVIR SULFATE
- Registry number
- 188062-50-2
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- 2C14H18N6O.H2O4S
Chemical And Database Identifiers#
- InChIKey
- WMHSRBZIJNQHKT-FFKFEZPRSA-N
- SMILES
- OS(O)(=O)=O.NC1=NC2=C(N=CN2[C@@H]3C[C@H](CO)C=C3)C(NC4CC4)=N1.NC5=NC6=C(N=CN6[C@@H]7C[C@H](CO)C=C7)C(NC8CC8)=N5
- RxCUI
- 221052
- PubChem
- 441384
- NCIt
- C28804
- INN ID
- 0
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | These highlights do not include all the information needed to use TRIZIVIR safely and effectively. See full prescribing information for TRIZIVIR. TRIZIVIR (abacavir sulfate, lamivudine, and zidovudine) Tablets, for oral use Initial U.S. Approval: 2000 | 2 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | These highlights do not include all the information needed to use abacavir tablets safely and effectively. See full prescribing information for abacavir tablets. Abacavir Tablets, USP for Oral Use Initial U.S. Approval: 1998 | 1 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | EPZICOM ® (abacavir sulfate and lamivudine) Tablets | 1 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | EPZICOM ® (abacavir sulfate and lamivudine) Tablets | 2 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | These highlights do not include all the information needed to use ZIAGEN safely and effectively. See full prescribing information for ZIAGEN. ZIAGEN ® (abacavir sulfate) Tablets and Oral Solution Initial U.S. Approval: 1998 | 1 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | ZIAGEN (ABACAVIR SULFATE) TABLET, FILM COATED ZIAGEN (ABACAVIR SULFATE) SOLUTION [VIIV HEALTHCARE COMPANY] | 17 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | TRIZIVIR (ABACAVIR SULFATE, LAMIVUDINE, AND ZIDOVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 16 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 15 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | ABACAVIR SULFATE TABLET, FILM COATED [MYLAN PHARMACEUTICALS INC.] | 8 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | ABACAVIR SULFATE TABLET, FILM COATED [APOTEX CORP] | 6 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | ABACAVIR (ABACAVIR SULFATE) TABLET, FILM COATED [AUROBINDO PHARMA LIMITED] | 5 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | ABACAVIR SULFATE, LAMIVUDINE AND ZIDOVUDINE TABLET [LUPIN PHARMACEUTICALS, INC.] | 5 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | TRIUMEQ (ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE) TABLET, FILM COATED [VIIV HEALTHCARE COMPANY] | 5 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | ABACAVIR SULFATE TABLET, FILM COATED [MYLAN INSTITUTIONAL INC.] | 3 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | ABACAVIR (ABACAVIR SULFATE) TABLET, FILM COATED [AMERICAN HEALTH PACKAGING] | 2 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | ABACAVIR SULFATE TABLET, FILM COATED [REMEDYREPACK INC. ] | 2 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | ABACAVIR TABLET [CAMBER PHARMACEUTICALS, INC.] | 2 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | ABACAVIR TABLET [REMEDYREPACK INC. ] | 2 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | EPZICOM (ABACAVIR SULFATE AND LAMIVUDINE) TABLET, FILM COATED [REMEDYREPACK INC. ] | 1 | |
| ABACAVIR SULFATE | ACTIVE INGREDIENT | J220T4J9Q2 | ZIAGEN (ABACAVIR SULFATE) TABLET, FILM COATED [REMEDYREPACK INC. ] | 1 | |